Madrigal Pharmaceuticals, Inc. (MDGL)
Madrigal Pharmaceuticals Market Cap: 12.57B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 170.35B |
| Alnylam Pharmaceuticals, Inc. | 54.30B |
| Amicus Therapeutics, Inc. | 3.048B |
| Insmed, Inc. | 41.61B |
| Ionis Pharmaceuticals, Inc. | 12.80B |
Market Cap Related Metrics
| PS Ratio | 16.57 |
| Price to Book Value | 20.08 |
| Price | 553.33 |
| Earnings Yield | -2.35% |